Search results
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 6 days agoMelanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower...
Michael Mosley: How the presenter transformed people's lives
BBC via Yahoo News· 4 hours ago“I discovered that almost all the great medical discoveries were made by self-experimenters, whether...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 5 days agoHe was willing to do whatever he could to ensure his three children would avoid that fate, too. So,...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 6 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 6 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 7 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 7 days agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor...
Cow burps are a major source of methane emissions. A Boston startup is working on a vaccine to fix...
The Boston Globe· 3 days agoFounded in 2021, the privately held startup has been testing a vaccine candidate for about a year in...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoSo far, three people in the U.S. have been sickened by the bird flu following contact with infected...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 5 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...